Head injuries worsen memory and thinking decades later
Head injuries worsen memory and thinking decades later
Provider: View Original
Type: Link
Title: Head injuries worsen memory and thinking decades later | Alzheimer's Research UK
Description: Alzheimer's Research UK fund research that finds link between head injuries and risk of memory and thinking decline decades later.
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
![](https://adpd.kenes.com/wp-content/uploads/sites/102/2020/10/adpd21-virtual-share-banner-1200x628-1.png)
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Provider: AD/PD™ 2021 | March 9 - 14, 2021 | Virtual Conference
Type: Link
Title: Alzheimer's & Parkinson's Diseases Conference AD/PD™ 2021 Virtual Conference
Description: Join us in online for AD/PD™ 2021, the 15th edition of the groundbreaking series of conferences on Alzheimer's and Parkinson's Diseases.
![](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/0/nejm.ahead-of-print/nejmoa2100708/20210312/images/img_small/nejmoa2100708_f1.jpeg)
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Provider: New England Journal of Medicine
Type: Link
Title: Donanemab in Early Alzheimer’s Disease | NEJM
Description: Original Article from The New England Journal of Medicine — Donanemab in Early Alzheimer’s Disease
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Provider: Alzheimersresearchuk
Type: JPG
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2015/04/ARUK-MRI-007-scaled.jpg)
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Phase 2 trial results show donanemab may slow decline in early Alzheimer’s | Alzheimer's Research UK
Description: Data from a trial of the drug donanemab suggests the treatment may be able to slow decline in people with early Alzheimer's disease.
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/03/header-video_thumb.png)
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Provider: View Original
Type: Link
Title: Phase 2 trial results show donanemab may slow decline in early Alzheimer’s | Alzheimer's Research UK
Description: Data from a trial of the drug donanemab suggests the treatment may be able to slow decline in people with early Alzheimer's disease.
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
Provider: Thelancet
Type: Link
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
Provider: Ons
Type: Link
Title: Deaths in private homes, England and Wales (provisional) - Office for National Statistics
Description: Provisional figures on deaths in private homes in England and Wales.
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
Provider: Alzheimersresearchuk
Type: JPG
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2019/03/Rob-Howard.jpg)
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
Provider: Alzheimer's Research UK
Type: Link
Title: COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects | Alzheimer's Research UK
Description: New research published in the Lancet online finds that not only are dementia deaths up 79% (ONS figures – 19th Oct) compared to previous years but the prescription rates of antipsychotic drugs to people with dementia have also increased during COVID-19. Although the absolute number of antipsychotic prescriptions for people with dementia decreased, reductions in…
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/03/header-video_thumb.png)
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects
Provider: View Original
Type: Link
Title: COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects | Alzheimer's Research UK
Description: New research published in the Lancet online finds that not only are dementia deaths up 79% (ONS figures – 19th Oct) compared to previous years but the prescription rates of antipsychotic drugs to people with dementia have also increased during COVID-19. Although the absolute number of antipsychotic prescriptions for people with dementia decreased, reductions in…
Dame Julie Walters urges government to keep its promise on dementia research funding
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/12/sign-petition-thankyou-scaled.jpg)
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimer's Research UK
Type: Link
Title: Dementia Research at Risk Petition
Description: We must protect the future of dementia research. The government made an election pledge to double funding for dementia research to over £160 million a year. Together, we can make sure they keep their promise.
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/12/sign-petition-thankyou-scaled.jpg)
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimer's Research UK
Type: Link
Title: Dementia Research at Risk Petition
Description: We must protect the future of dementia research. The government made an election pledge to double funding for dementia research to over £160 million a year. Together, we can make sure they keep their promise.
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimersresearchuk
Type: JPG
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimersresearchuk
Type: JPG
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/12/sign-petition-thankyou-scaled.jpg)
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimer's Research UK
Type: Link
Title: Dementia Research at Risk Petition
Description: We must protect the future of dementia research. The government made an election pledge to double funding for dementia research to over £160 million a year. Together, we can make sure they keep their promise.
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2021/03/Dame-Julie-Walters-scaled.jpg)
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimer's Research UK
Type: Link
Title: Dame Julie Walters urges government to keep its promise on dementia research funding | Alzheimer's Research UK
Description: Dame Julie Walters is joining over 43,000 people and backing a petition calling on the UK government to deliver on its election promise to double funding for dementia research.
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/03/header-video_thumb.png)
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Dame Julie Walters urges government to keep its promise on dementia research funding
Provider: View Original
Type: Link
Title: Dame Julie Walters urges government to keep its promise on dementia research funding | Alzheimer's Research UK
Description: Dame Julie Walters is joining over 43,000 people and backing a petition calling on the UK government to deliver on its election promise to double funding for dementia research.
Poorer heart health leads to increased risk of memory and thinking decline
![](https://www.nhs.uk/static/nhsuk/img/default-social-image.a74435697f45.png)
Poorer heart health leads to increased risk of memory and thinking decline
Provider: nhs.uk
Type: Link
Title: BMI calculator | Check your BMI
Description: Check your BMI and understand your result
![](https://www.nhs.uk/static/nhsuk/img/default-social-image.a74435697f45.png)
Poorer heart health leads to increased risk of memory and thinking decline
Provider: nhs.uk
Type: Link
Title: BMI calculator | Check your BMI
Description: Check your BMI and understand your result
Poorer heart health leads to increased risk of memory and thinking decline
Provider: Alzheimersresearchuk
Type: JPG
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2021/03/Heart.jpg)
Poorer heart health leads to increased risk of memory and thinking decline
Provider: Alzheimer's Research UK
Type: Link
Title: Poorer heart health leads to increased risk of memory and thinking decline | Alzheimer's Research UK
Description: Researchers find signs of poorer heart health during early life, are linked with greater late-life decline in memory skills.
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/03/header-video_thumb.png)
Poorer heart health leads to increased risk of memory and thinking decline
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Poorer heart health leads to increased risk of memory and thinking decline
Provider: View Original
Type: Link
Title: Poorer heart health leads to increased risk of memory and thinking decline | Alzheimer's Research UK
Description: Researchers find signs of poorer heart health during early life, are linked with greater late-life decline in memory skills.
Dementia the second leading cause of death in February
Dementia the second leading cause of death in February
Provider: Alzheimersresearchuk
Type: JPG
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/12/sign-petition-thankyou-scaled.jpg)
Dementia the second leading cause of death in February
Provider: Alzheimer's Research UK
Type: Link
Title: Dementia Research at Risk Petition
Description: We must protect the future of dementia research. The government made an election pledge to double funding for dementia research to over £160 million a year. Together, we can make sure they keep their promise.
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2018/06/ARUK_Lab_Alex_Wallace_Photography_321.jpg)
Dementia the second leading cause of death in February
Provider: Alzheimer's Research UK
Type: Link
Title: Dementia the second leading cause of death in February | Alzheimer's Research UK
Description: Dementia remains our greatest long-term health challenge, says Alzheimer's Research UK
![](https://www.alzheimersresearchuk.org/wp-content/uploads/2020/03/header-video_thumb.png)
Dementia the second leading cause of death in February
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Dementia the second leading cause of death in February
Provider: View Original
Type: Link
Title: Dementia the second leading cause of death in February | Alzheimer's Research UK
Description: Dementia remains our greatest long-term health challenge, says Alzheimer's Research UK